NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the NAPLEX exam with a comprehensive quiz featuring multiple-choice questions and in-depth explanations. Build your pharmacological knowledge and increase your chances of passing the pharmacist licensure examination!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

Which MS treatment is known for causing chest pain as a warning?

Copaxone
Aubagio
Mayzent
Lupkynis

The correct answer is: Copaxone

Copaxone, an injectable treatment for multiple sclerosis (MS), is known to cause chest pain as a warning sign. This is due to the medication's potential to cause a condition called lipoatrophy, which is a loss of fat under the skin, leading to indentations or growths on the skin. This can occur at the site of the injection and may cause chest pain as a warning sign for patients to seek medical attention. It is important for patients to carefully monitor their injection sites and report any unusual symptoms or changes to their healthcare provider. The other options listed (Aubagio, Mayzent, and Lupkynis) are not known to cause chest pain as a warning sign. Aubagio may cause unpleasant side effects, such as stomach pain, headache, and diarrhea, but this is not specific to chest pain. Mayzent and Lupkynis do not list chest pain as a potential side effect.